Nutropin AQ Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Alerts
• Clinical Trials

Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Condition:   Pediatric Growth Hormone Deficiency Interventions:   Drug: MOD-4023;   Drug: Somatropin Sponsor:   Opko Biologics Not yet recruiting - verified October 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2016 Category: Research Source Type: clinical trials

A Phase 3, Open-label, Randomized, Multicenter, 12 Months, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin - Therapy in Pre-pubertal Children With Growth Hormone Deficiency
Condition:   Pediatric Growth Hormone Deficiency Interventions:   Drug: MOD-4023;   Drug: Somatropin Sponsor:   Opko Biologics Not yet recruiting - verified October 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2016 Category: Research Source Type: clinical trials